Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.66% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.55% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Communication Services | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Altimmune
ALT
$560M
| $7.45M | ﹤0.01% |
658,852
+123,336
| +23% | +$1.5M |
|
|
AERI
2677
DELISTED
Aerie Pharmaceuticals
AERI
| $7.45M | ﹤0.01% |
653,610
-102,604
| -14% | -$1.5M |
|
|
IDEX
2678
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $7.45M | ﹤0.01% |
30,236
+952
| +3% | +$277K |
|
|
WSR
2679
DELISTED
Whitestone REIT
WSR
| $7.44M | ﹤0.01% |
761,033
+30,979
| +4% | +$284K |
|
2680
Accuray
ARAY
$32.9M
| $7.44M | ﹤0.01% |
1,883,058
+33,118
| +2% | +$131K |
|
2681
Immunovant
IMVT
$8.64B
| $7.44M | ﹤0.01% |
855,908
+8,798
| +1% | +$79.4K |
|
2682
Avita Medical
RCEL
$248M
| $7.43M | ﹤0.01% |
419,601
+4,928
| +1% | +$93K |
|
2683
Forestar Group
FOR
$1.49B
| $7.41M | ﹤0.01% |
397,885
+23,639
| +6% | +$477K |
|
|
SGFY
2684
DELISTED
Signify Health, Inc.
SGFY
| $7.39M | ﹤0.01% |
413,669
+142,951
| +53% | +$3.68M |
|
|
ICPT
2685
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $7.39M | ﹤0.01% |
497,636
+8,971
| +2% | +$144K |
|
|
TBCH
2686
Turtle Beach Corp
TBCH
$230M
| $7.38M | ﹤0.01% |
265,252
+2,393
| +0.9% | +$69.8K |
|
2687
Krispy Kreme
DNUT
$569M
| $7.37M | ﹤0.01% |
+526,524
| New | +$8.45M |
|
2688
American Superconductor
AMSC
$1.53B
| $7.35M | ﹤0.01% |
504,436
+65,260
| +15% | +$905K |
|
2689
AvePoint
AVPT
$2.91B
| $7.32M | ﹤0.01% |
862,015
+842,684
| +4,359% | +$8.39M |
|
2690
Hims & Hers Health
HIMS
$6.71B
| $7.32M | ﹤0.01% |
970,181
+409,486
| +73% | +$3.47M |
|
|
MOFG
2691
DELISTED
MidWestOne Financial Group
MOFG
| $7.31M | ﹤0.01% |
242,526
-12
| -0% | -$350 |
|
2692
REX American Resources
REX
$1.44B
| $7.31M | ﹤0.01% |
549,072
+15,768
| +3% | +$213K |
|
2693
MVB Financial
MVBF
$397M
| $7.28M | ﹤0.01% |
169,918
+2,871
| +2% | +$117K |
|
2694
IMAX
IMAX
$2.92B
| $7.27M | ﹤0.01% |
383,146
-43,370
| -10% | -$720K |
|
2695
Vishay Precision Group
VPG
$908M
| $7.25M | ﹤0.01% |
208,622
+2,053
| +1% | +$74.5K |
|
2696
CRISPR Therapeutics
CRSP
$5.22B
| $7.21M | ﹤0.01% |
64,455
+600
| +0.9% | +$75.4K |
|
|
ASXC
2697
DELISTED
Asensus Surgical, Inc.
ASXC
| $7.21M | ﹤0.01% |
3,898,267
+114,499
| +3% | +$257K |
|
2698
UFP Technologies
UFPT
$2.48B
| $7.21M | ﹤0.01% |
117,068
+443
| +0.4% | +$28K |
|
2699
W&T Offshore
WTI
$546M
| $7.21M | ﹤0.01% |
1,937,959
-29,840
| -2% | -$107K |
|
2700
Cartesian Therapeutics
RNAC
$262M
| $7.2M | ﹤0.01% |
57,709
+3,634
| +7% | +$439K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.